HERON THERAPEUTICS, INC. /DE/ Effective Income Tax Rate Reconciliation, Other Adjustments, Amount
HERON THERAPEUTICS, INC. /DE/ (HRTX) reported Effective Income Tax Rate Reconciliation, Other Adjustments, Amount of $210.00 thousand for the 12-month period ending 2012-12-31, per its 10-K filed 2013-03-01.
Discontinued › Expense Statement › Income Tax
us-gaap:IncomeTaxReconciliationOtherAdjustments · last filed 2013-03-01
- HERON THERAPEUTICS, INC. /DE/ effective income tax rate reconciliation, other adjustments, amount for fiscal 2012 was $210.00K, a 200.00% increase from fiscal 2011.
- HERON THERAPEUTICS, INC. /DE/ effective income tax rate reconciliation, other adjustments, amount for fiscal 2011 was $70.00K, a 16.67% decline from fiscal 2010.
- HERON THERAPEUTICS, INC. /DE/ effective income tax rate reconciliation, other adjustments, amount for fiscal 2010 was $84.00K.
| Period end | Effective Income Tax Rate Reconciliation, Other Adjustments, Amount 12 month |
|---|---|
| 2012-12-31 | $210.00K 10-K · filed 2013-03-01 |
| 2011-12-31 | $70.00K 10-K · filed 2013-03-01 |
| 2010-12-31 | $84.00K 10-K · filed 2013-03-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Clene Inc. (CLNN) | United States | $0.054B | -1.99 |
| Serina Therapeutics, Inc. (SER) | United States | $0.054B | -2.35 |
| Annovis Bio, Inc. (ANVS) | United States | $0.056B | -1.58 |
| Xilio Therapeutics, Inc. (XLO) | United States | $0.052B | |
| NOMAD POWER SOLUTIONS, INC. (NMAD) | United States | $0.058B | |
| Boundless Bio, Inc. (BOLD) | United States | $0.059B | -0.88 |
| TALPHERA, INC. (TLPH) | United States | $0.060B | |
| Elicio Therapeutics, Inc. (ELTX) | United States | $0.049B | |
| CalciMedica, Inc. (CALC) | United States | $0.061B | -1.42 |
| Lite Strategy, Inc. (LITS) | United States | $0.049B |